Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05199285 |
Title | Nivolumab and Ipilimumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Liver Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Academic and Community Cancer Research United |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Alabama- Birmingham | RECRUITING | Birmingham | Alabama | 35233 | United States | Details |
University of Miami Miller School of Medicine-Sylvester Cancer Center | RECRUITING | Miami | Florida | 33136 | United States | Details |
Emory University Hospital/Winship Cancer Institute | NOT_YET_RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
Mayo Clinic in Rochester | NOT_YET_RECRUITING | Rochester | Minnesota | 55905 | United States | Details |
Rutgers Cancer Institute of New Jersey | RECRUITING | New Brunswick | New Jersey | 08903 | United States | Details |
Vanderbilt University/Ingram Cancer Center | RECRUITING | Nashville | Tennessee | 37232 | United States | Details |